Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to pulmonary tuberculosis in Han Chinese

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 785-789

  Xue, Yun ^a   Jin, Lei ^a   Li, A Zhong ^b   Wang, Hua Jun ^c   Li, Meng ^a   Zhang, Yu Xiang ^a   Wang, Yu ^d   Li, Ji Cheng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BLOOD CENTER OF ZHEJIANG PROVINCE   (China)

^c Sixth Hospital of Shaoxing   (China)

^d CHANGCHUN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Microsatellite polymorphism; Pulmonary tuberculosis; Toll like receptor 2

Indexed keywords

CD14 ANTIGEN; GUANINE; THYMINE; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; INTRON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR GENE;

ADOLESCENT; ADULT; AGED; ALLELES; ANTIGENS, CD14; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS, PULMONARY;

EID: 77953187613     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.154     Document Type: Article

References (33)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006;367: 938-940
2. World Health Organization. The World Health Report 2004: changing History. Geneva: World Health Organization, 2004.
3. Rosman MD, Oner-Eyupoglu AF. Clinical presentation and treatment of tuberculosis. In: Fishman AP, editor. Fishman's pulmonary diseases and disorders. New York: McGraw-Hill; 1998. p. 2483-2502
4. Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004;23: 219-223
5. Shim TS, Turner OC, Orme IM. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2003;83:367-371
6. Sugawara I, Yamada H, Li C, Mizuno S, Takeuchi O, Akira S. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol 2003;47:327-336 (Pubitemid 36604618)
7. Sugawara I, Yamada H, Mizuno S, Takeda K, Akira S. Mycobacterial infection in MyD88-deficient mice. Microbiol Immunol 2003;47:841-847
8. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-298
9. Heldwein KA, Fenton MJ. The role of toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002;4:937-944
10. Jones BW, Heldwein KA, Means TK, Saukkonen JJ, Fenton MJ. Differential roles of toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis 2001;60(Suppl 3):iii6-12.
11. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 2002;99: 1503-1508
12. Kopp EB, Medzhitov R. The toll-receptor family and control of innate immunity. Curr Opin Immunol 1999;11:13-18
13. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999;96: 14459-14463
14. Schnare M, Rollinghoff M, Qureshi S. Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 2006;139:75-85.
15. Verstak B, Hertzog P, Mansell A. Toll-like receptor signalling and the clinical benefits that lie within. Inflamm Res 2007;56: 1-10.
16. Wetzler LM. The role of toll-like receptor 2 in microbial disease and immunity. Vaccine 2003;21(Suppl 2):S55-60.
17. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, Goyert S, et al. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169:3480-3484
18. Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 2004;11:625-626
19. Yim JJ, Lee HW, Lee HS, Kim YW, Han SK, Shim YS, et al. The association between microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene and tuberculosis among Koreans. Genes Immun 2006;7:150-155
20. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235
21. Drennan MB, Nicolle D, Quesniaux VJ, Jacobs M, Allie N, Mpagi J, et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 2004;164: 49-57.
22. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002;186:1463-1468
23. Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, Marchant A, et al. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia. Tuberculosis (Edinb) 2004;84:347-352
24. Hawn TR, Dunstan SJ, Thwaites GE, Simmons CP, Thuong NT, Lan NT, et al. A polymorphism in toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis 2006;194: 1127-1134
25. Nejentsev S, Thye T, Szeszko JS, Stevens H, Balabanova Y, Chinbuah AM, et al. Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations. Nat Genet 2008;40:261-262
26. Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis. J Infect Dis 2007;196:1698-1706
27. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003;361:1871-1872
28. Schroder NW, Schumann RR. Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005;5:156-164
29. Veltkamp M, Wijnen PA, van Moorsel CH, Rijkers GT, Ruven HJ, Heron M, et al. Linkage between toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 2007;149:453-462
30. Qiu L, Huang D, Chen CY, Wang R, Shen L, Shen Y, et al. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP- 10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 2008;198:1514-1519
31. Rocha-Ramirez LM, Estrada-Garcia I, Lopez-Marin LM, Segura- Salinas E, Mendez-Aragon P, Van Soolingen D, et al. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb) 2008;88:212-220
32. Aleman M, Schierloh P, de la Barrera SS, Musella RM, Saab MA, Baldini M, et al. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infect Immun 2004;72:5150-5158
33. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, et al. Bacterial lipopolysaccharide activates NFkappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 2000;275:11058-11063